Downregulation of the expression of the main immunoglobulin V(H) family in HIV-infected patients: modulation by triple combination therapy.
David
D
D
Pirès
R
R
Treilhou
M P
MP
Dupont
B
B
Joussemet
M
M
Pialoux
G
G
Thèze
J
J
Bouvet
J P
JP
D000328:Adult; D000368:Aged; D019380:Anti-HIV Agents / Q000627:therapeutic use*; D002648:Child; D002675:Child, Preschool; D015536:Down-Regulation; D004359:Drug Therapy, Combination; D005260:Female; D015658:HIV Infections / Q000188:drug therapy* / Q000276:immunology*; D017320:HIV Protease Inhibitors / Q000627:therapeutic use; D006801:Humans; D007128:Immunoglobulin Fragments; D007074:Immunoglobulin G / Q000097:blood / Q000378:metabolism; D007143:Immunoglobulin Heavy Chains / Q000097:blood / Q000502:physiology*; D007135:Immunoglobulin Variable Region / Q000097:blood / Q000502:physiology*; D008222:Lymphokines / Q000378:metabolism; D008297:Male; D008875:Middle Aged; D018894:Reverse Transcriptase Inhibitors / Q000627:therapeutic use; D012795:Sialoglycoproteins / Q000378:metabolism; D018089:Superantigens / Q000276:immunology
D019380:Anti-HIV Agents; C089422:Fv protein, human; D017320:HIV Protease Inhibitors; D007128:Immunoglobulin Fragments; D007074:Immunoglobulin G; D007143:Immunoglobulin Heavy Chains; D007135:Immunoglobulin Variable Region; D008222:Lymphokines; D018894:Reverse Transcriptase Inhibitors; D012795:Sialoglycoproteins; D018089:Superantigens